Nuveen Asset Management, LLC Ionis Pharmaceuticals Inc Transaction History

Nuveen Asset Management, LLC

$334 Billion
Q2 2024

A detailed history of Nuveen Asset Management, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 410,404 shares of IONS stock, worth $16.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

410,404

Previous 423,030 2.98%

Holding current value

$16.8 Million

Previous $18.3 Million 6.66%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$36.45 - $47.7 $460,217 - $602,260	-12,626 Reduced 2.98%	410,404 $19.6 Million
Q1 2024 May 13, 2024	BUY	$42.03 - $53.55 $4.16 Million - $5.3 Million	99,024 Added 30.56%	423,030 $18.3 Million
Q4 2023 Feb 14, 2024	BUY	$43.39 - $51.63 $644,862 - $767,325	14,862 Added 4.81%	324,006 $16.4 Million
Q3 2023 Nov 14, 2023	SELL	$38.5 - $47.13 $1.24 Million - $1.52 Million	-32,307 Reduced 9.46%	309,144 $14 Million
Q2 2023 Aug 16, 2023	SELL	$34.73 - $43.33 $1.03 Million - $1.28 Million	-29,550 Reduced 7.96%	341,451 $14 Million
Q2 2023 Aug 14, 2023	BUY	$34.73 - $43.33 $1.98 Million - $2.48 Million	57,136 Added 18.2%	371,001 $15.2 Million
Q1 2023 May 15, 2023	SELL	$33.58 - $41.2 $312,730 - $383,695	-9,313 Reduced 2.88%	313,865 $11.2 Million
Q4 2022 Feb 14, 2023	SELL	$37.12 - $46.52 $597,854 - $749,251	-16,106 Reduced 4.75%	323,178 $12.2 Million
Q3 2022 Nov 14, 2022	SELL	$36.54 - $48.66 $343,549 - $457,501	-9,402 Reduced 2.7%	339,284 $15 Million
Q2 2022 Aug 15, 2022	BUY	$31.71 - $43.0 $1.04 Million - $1.41 Million	32,867 Added 10.41%	348,686 $12.9 Million
Q1 2022 May 16, 2022	SELL	$29.88 - $37.04 $1.07 Million - $1.32 Million	-35,657 Reduced 10.14%	315,819 $11 Million
Q4 2021 Feb 14, 2022	SELL	$25.61 - $35.1 $7.09 Million - $9.72 Million	-277,000 Reduced 44.07%	351,476 $10.7 Million
Q3 2021 Nov 12, 2021	SELL	$33.54 - $40.55 $3.17 Million - $3.84 Million	-94,625 Reduced 13.09%	628,476 $21.1 Million
Q2 2021 Aug 16, 2021	SELL	$34.54 - $47.25 $7.81 Million - $10.7 Million	-226,136 Reduced 23.82%	723,101 $28.8 Million
Q1 2021 May 17, 2021	BUY	$42.51 - $63.78 $14.1 Million - $21.1 Million	330,826 Added 53.5%	949,237 $42.7 Million
Q4 2020 May 17, 2021	BUY	$45.3 - $60.27 $536,578 - $713,898	11,845 Added 1.95%	618,411 $35 Million
Q4 2020 Feb 16, 2021	BUY	$45.3 - $60.27 $8.14 Million - $10.8 Million	179,668 Added 42.09%	606,566 $34.3 Million
Q3 2020 Nov 16, 2020	SELL	$47.45 - $62.95 $2.44 Million - $3.24 Million	-51,403 Reduced 10.75%	426,898 $20.3 Million
Q2 2020 Aug 14, 2020	BUY	$46.85 - $61.05 $50,316 - $65,567	1,074 Added 0.23%	478,301 $28.2 Million
Q1 2020 May 14, 2020	BUY	$41.6 - $63.4 $2,828 - $4,311	68 Added 0.01%	477,227 $22.6 Million
Q4 2019 Feb 14, 2020	SELL	$53.85 - $65.27 $1.19 Million - $1.44 Million	-22,028 Reduced 4.41%	477,159 $28.8 Million
Q3 2019 Nov 14, 2019	BUY	$59.06 - $72.15 $961,378 - $1.17 Million	16,278 Added 3.37%	499,187 $29.9 Million
Q2 2019 Aug 15, 2019	BUY	$62.09 - $86.14 $29.2 Million - $40.5 Million	470,539 Added 3803.87%	482,909 $31 Million
Q1 2019 May 14, 2019	BUY	$52.92 - $81.17 $42,336 - $64,936	800 Added 6.91%	12,370 $1 Million
Q4 2018 Feb 14, 2019	BUY	$43.37 - $59.54 $501,790 - $688,877	11,570 New	11,570 $625,000
Q3 2018 Nov 13, 2018	SELL	$42.88 - $53.7 $478,240 - $598,916	-11,153 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$44.08 - $55.05 $969,760 - $1.21 Million	-22,000 Reduced 66.36%	11,153 $492,000
Q4 2017 Feb 14, 2018	SELL	$50.3 - $64.39 $789,710 - $1.01 Million	-15,700 Reduced 32.14%	33,153 $0
Q3 2017 Nov 14, 2017	BUY	$45.56 - $59.57 $2.23 Million - $2.91 Million	48,853	48,853 $2.48 Million

Others Institutions Holding IONS

# of Institutions

394

Shares Held

125M

Call Options Held

2.25M

Put Options Held

510K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.8B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Ionis Pharmaceuticals Inc Transaction History